MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-27-0003597
Shuddha Pharmaceuticals Private Limited
Shuddha Pharmaceuticals Private Limited - pharma in Pen, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹23,000
▼ 85% YoY
Net loss · FY 2025
₹2.55 Lakh
Latest filing
EBITDA · FY 2025
-₹64,252
EBITDA margin -279.4%
Authorised capital
₹30,000
Registered with MCA
Paid-up capital
₹30,000
Issued & subscribed
Open charges
₹15 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
About Shuddha Pharmaceuticals Private Limited
Data last updated:
Shuddha Pharmaceuticals Private Limited is a private limited company based in Pen, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2020PTC344440. Its GSTIN is 27ABECS2679F1Z3 (Maharashtra).
The company has an authorised share capital of ₹30,000 and a paid-up capital of ₹30,000. It is led by directors Deval Devidas Bamane and Sandip Bhikulal Katke.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G No. 4 Rohini Apartment Godavarital, Pen, Maharashtra, India – 402107.
As per the financials filed for FY 2025, the company reported a revenue of ₹23,000, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹2.55 Lakh and EBITDA of -₹64,252 (EBITDA margin -279.4%). Revenue has declined at a compounded annual rate (CAGR) of 40% over three years.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
Shuddha Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0003597).
Company details
CIN U51909MH2020PTC344440
Registration Number 344440
Incorporation Date 24 August 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-27-0003597
Recognitions & Rankings of Shuddha Pharmaceuticals
Contact details
Shuddha Pharmaceuticals Private Limited's registered office is in Pen, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG No. 4 Rohini Apartment Godavarital, Pen, Maharashtra, India – 402107
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Shuddha Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Shuddha Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Shuddha Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Shuddha Pharmaceuticals Private Limited, buy the company report.
Financials of Shuddha Pharmaceuticals Private Limited
FY 2025 filings availableShuddha Pharmaceuticals Private Limited reported revenue of ₹23,000 (down 85% YoY) for FY 2025.
Revenue · FY 2025
₹23,000 ▼ 85%
Net loss · FY 2025
₹2.55 Lakh
EBITDA · FY 2025
-₹64,252 margin -279.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 85%
3 years · compounded
▼ 40%
EBITDA CAGR growth
1 year
▲ 66%
3 years · compounded
▲ 59%
Revenue has declined at a compounded annual rate (CAGR) of 40% over three years, including a 85% fall in the latest year. EBITDA rose 66% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹64,252 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -279.4% | ||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shuddha Pharmaceuticals Private Limited, buy the company report.
Board of directors of Shuddha Pharmaceuticals Private Limited
Shuddha Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deval Devidas Bamane | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Sandip Bhikulal Katke | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
Auditor
Shuddha Pharmaceuticals Private Limited is audited by MANGESHVINAYAKCHITALE for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MANGESHVINAYAKCHITALE | FY 2023 | 152215 |
Shareholding
The shareholding of Shuddha Pharmaceuticals Private Limited is on record for FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Shuddha Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Mar 2021 | 100424470 | State Bank of India | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Shuddha Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shuddha Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Shuddha Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
Active EPFO establishments
1
GST
Shuddha Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABECS2679F1Z3 | Maharashtra | Active | 10 Sep 2020 |
To see the full GST registrations and return filing status of Shuddha Pharmaceuticals Private Limited, buy the company report.
Recent activity
Shuddha Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Sunil Laxman Harer ceased to be Director on 28 Feb 2025.
AGM
Shuddha Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Shuddha Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Sunil Laxman Harer ceased to be Director.
Charges
A charge with State Bank Of India amounted to Rs. 1,500,000.00 with Charge ID 100424470 was registered on 06 Mar 2021.
Appointed
Deval Devidas Bamane was appointed as Director.
Appointed
Sandip Bhikulal Katke was appointed as Director.
Incorporation
24 Aug 2020
Shuddha Pharmaceuticals Private Limited was registered on 24 Aug 2020 with Roc Mumbai & aged 6 years 2 months as per MCA records.
Frequently asked questions
Shuddha Pharmaceuticals is an active private limited company based in Pen, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 August 2020 (6+ years old) and is registered under CIN U51909MH2020PTC344440.
Shuddha Pharmaceuticals has 2 current directors:
- Deval Devidas Bamane - Director
- Sandip Bhikulal Katke - Director
The latest financial statements of Shuddha Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Shuddha Pharmaceuticals is 27ABECS2679F1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Shuddha Pharmaceuticals is U51909MH2020PTC344440. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shuddha Pharmaceuticals was incorporated on 24 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Sunil Laxman Harer ceased to be Director on 28 Feb 2025. Deval Devidas Bamane was appointed as Director on 24 Aug 2020. Sandip Bhikulal Katke was appointed as Director on 24 Aug 2020.
Yes, Shuddha Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0003597).
The registered office of Shuddha Pharmaceuticals is at G No. 4 Rohini Apartment Godavarital, Pen, Maharashtra, India – 402107.
Shuddha Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages